Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion type Assertion NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_head.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion description "[In the human mycobacterial infection leprosy, we found that activation of monocytes via nucleotide-binding oligomerization domain-containing protein 2 (NOD2) by its ligand muramyl dipeptide, as compared to activation via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1) by triacylated lipopeptide, preferentially induced differentiation into dendritic cells (DCs), which was dependent on a previously unknown interleukin-32 (IL-32)-dependent mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_provenance.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion evidence source_evidence_literature NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_provenance.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion SIO_000772 22447076 NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_provenance.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion wasDerivedFrom befree-20140225 NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_provenance.
- NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_assertion wasGeneratedBy ECO_0000203 NP880759.RAS9ZIUT9tqFDKQF_6zlbeZdV8qG3IKS0E2V7Gyhy36BQ130_provenance.